Approval · Notice of Compliance 11332 · 2010
METFORMIN: Notice of Compliance 11332
Issued April 29, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11332
- Date
- April 29, 2010
- Company
- Public Benefits PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Oral antihyperglycemic agent
- Canadian reference product
- GLUCOPHAGE (Hoechst Marion Roussel Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METFORMIN | 02350289 | — |
| METFORMIN | 02350300 | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB